Novo Nordisk chairman: We must make heaps of strong leaders for ourselves – and for other companies

As chairman of the board at Denmark's most valuable company, Helge Lund emphasizes that Novo Nordisk should not just create its own leaders, but also make leaders for other companies.

Novo Nordisk Chairman of the Board | Photo: Yana Lapikova/AP/Ritzau Scanpix

Although Novo Nordisk has changed its practice for manning executive positions in recent years, its focus remains on cultivating internal candidates, according to the Novo Nordisk Chairman Helge Lund following recent developments within the pharmaceutical flagship, as it now has three company executives who have not been in the company for long.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs